Press releases

Media contact: Stéphanie Bardon – communication@genethon.fr – 01.69.47.12.78

Gene therapy: Production of the first batch of HIV-derived vectors in Europe for use in a human clinical trial

Genethon, the laboratory created and funded by the AFM (French Association against Myopathies) using donations from Téléthon, today announced that it has produced, controlled and released a batch of lentiviral vectors derived from the human immunodeficiency (HIV) virus for a gene therapy trial in humans in a rare immune deficiency. The… (read more)

Neuromuscular diseases: A pharmacological therapeutic approach for certain sarcoglycanopathies

(read more)